Mirova Eli Lilly & CO Transaction History

Mirova

$560 Million
Q1 2024

A detailed history of Mirova transactions in Eli Lilly & CO stock. As of the latest transaction made, Mirova holds 27,432 shares of LLY stock, worth $24.6 Million. This represents 3.81% of its overall portfolio holdings.

Number of Shares

27,432

Previous 21,712 26.34%

Holding current value

$24.6 Million

Previous $12.7 Million 68.62%

% of portfolio

3.81%

Previous 2.61%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$592.2 - $792.28 $3.39 Million - $4.53 Million	5,720 Added 26.34%	27,432 $21.3 Million
Q4 2023 Feb 13, 2024	SELL	$525.19 - $619.13 $1.29 Million - $1.52 Million	-2,456 Reduced 10.16%	21,712 $12.7 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $672,915 - $927,716	-1,548 Reduced 6.02%	24,168 $13 Million
Q2 2023 Aug 11, 2023	SELL	$350.74 - $468.98 $1.12 Million - $1.49 Million	-3,182 Reduced 11.01%	25,716 $12.1 Million
Q1 2023 May 12, 2023	BUY	$310.63 - $364.82 $32,305 - $37,941	104 Added 0.36%	28,898 $9.92 Million

Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $322,836 - $376,168	1,004 Added 3.61%	28,794 $10.5 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $4.92 Million - $5.61 Million	-16,596 Reduced 37.39%	27,790 $8.99 Million
Q2 2022 Aug 12, 2022	BUY	$278.73 - $327.27 $720,238 - $845,665	2,584 Added 6.18%	44,386 $14.4 Million
Q1 2022 May 13, 2022	BUY	$234.69 - $291.66 $3.16 Million - $3.93 Million	13,470 Added 47.54%	41,802 $12 Million
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $619,686 - $769,034	-2,756 Reduced 8.87%	28,332 $7.83 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $552,227 - $679,593	-2,492 Reduced 7.42%	31,088 $7.18 Million
Q2 2021 Aug 13, 2021	BUY	$180.55 - $233.54 $180,369 - $233,306	999 Added 3.07%	33,580 $7.71 Million
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $545,542 - $706,230	3,320 Added 11.35%	32,581 $6.09 Million
Q4 2020 Feb 12, 2021	BUY	$130.46 - $172.63 $919,612 - $1.22 Million	7,049 Added 31.74%	29,261 $4.94 Million
Q3 2020 Nov 12, 2020	BUY	$146.22 - $169.13 $84,515 - $97,757	578 Added 2.67%	22,212 $3.29 Million
Q2 2020 Aug 13, 2020	BUY	$136.42 - $164.18 $847,577 - $1.02 Million	6,213 Added 40.29%	21,634 $3.55 Million
Q1 2020 May 14, 2020	BUY	$119.05 - $147.35 $904,303 - $1.12 Million	7,596 Added 97.07%	15,421 $2.14 Million
Q4 2019 Feb 14, 2020	BUY	$106.92 - $132.43 $571,059 - $707,308	5,341 Added 215.02%	7,825 $1.03 Million
Q3 2019 Nov 13, 2019	BUY	$106.79 - $116.16 $13,455 - $14,636	126 Added 5.34%	2,484 $278,000
Q1 2019 May 15, 2019	BUY	$111.31 - $131.02 $163,180 - $192,075	1,466 Added 164.35%	2,358 $306,000
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $94,462 - $105,826	892 New	892 $103,000

Others Institutions Holding LLY

# of Institutions

3,722

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $853B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirova, based on Form 13F filings with the SEC.

News

Stay updated on Mirova with notifications on news.

Account